• Citer

A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyx) in the treatment of elderly patients with metastatic breast cancer.

par Biganzoli, Laura ;Coleman, R;Minisini, A;Hamilton, Andrew;Aapro, Matty;Therasse, P.;Mottino, Giuseppe;Bogaerts, J;Piccart-Gebhart, Martine
Référence Critical reviews in oncology/hematology, 61, 1, page (84-89)
Publication Publié, 2007-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyx) in the treatment of elderly patients with metastatic breast cancer.
Auteur:	Biganzoli, Laura; Coleman, R; Minisini, A; Hamilton, Andrew; Aapro, Matty; Therasse, P.; Mottino, Giuseppe; Bogaerts, J; Piccart-Gebhart, Martine
Informations sur la publication:	Critical reviews in oncology/hematology, 61, 1, page (84-89)
Statut de publication:	Publié, 2007-01
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Breast cancer
	Elderly
	Pegylated liposomal doxorubicin
MeSH keywords:	Adult
	Age Factors
	Aged
	Breast Neoplasms -- complications
	Breast Neoplasms -- drug therapy
	Breast Neoplasms -- mortality
	Clinical Trials, Phase I as Topic
	Clinical Trials, Phase II as Topic
	Comorbidity
	Dose-Response Relationship, Drug
	Doxorubicin -- administration & dosage
	Doxorubicin -- toxicity
	Drug Administration Schedule
	Drug Evaluation
	Humans
	Middle Aged
	Neoplasm Metastasis
	Retrospective Studies
	Treatment Outcome
Note générale:	Journal Article
Langue:	Anglais
Identificateurs:	urn:issn:1040-8428
	info:doi/10.1016/j.critrevonc.2006.07.008
	info:pii/S1040-8428(06)00167-3
	info:scp/33845332087
	info:pmid/17116400